Actavis to buy Warner Chilcott in $5 billion stock dealBy Caroline Humer and Ransdell Pierson (Reuters) - Generic drugmaker Actavis Inc, itself a recent takeover target, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc for $5 billion in stock to expand its branded drug portfolio, lower taxes and increase profits. The Warner Chilcott acquisition brings two new businesses - gastroenterology and dermatology - and adds additional women's health drugs like branded contraceptives to Actavis, which makes and sells drugs that are no longer under patent protection. ...
Source: Actavis to buy Warner Chilcott in $5 billion stock deal (http://news.yahoo.com/actavis-buy-warner-chilcott-8-5-billion-deal-112018951.html)